$7.0M
The seed round was led by The Discovery Lab of IBA to support product validation and laboratory expansion.
SB
Signatur Biosciences
Signatur Biosciences develops decentralised molecular diagnostic tests for local hospital use.
London, UK—Founded 2022
$7.0MTotal raised
Precision diagnostics startup developing decentralised molecular tests for cancer care.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Cash, assets and headcount from Signatur Biosciences's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Celestin de Wergifosse
CEO
Celestin is co-founder and CEO of Signatur Biosciences. He previously served as an entrepreneur in residence at Imperial College London and founded Celever.
LinkedIn